In January 2017, SYMBICORT 80/4.5 was approved for the treatment of asthma in patients aged six up to 12 years. SYMBICORT 80/4.5 and 160/4.5 were already approved in the US to treat asthma in ...

Symbicort (budesonide/formoterol) is a prescription drug that’s used to treat certain breathing conditions. Symbicort can cause side effects that range from mild to ...

Symbicort is a prescription drug that’s used to treat: chronic obstructive pulmonary disease (COPD) in adults asthma in adults and certain children The active ingredients in Symbicort are ...

As AstraZeneca fights to defend its aging two-drug inhaler Symbicort against generics ... approval in patients 4 and older. A first-in-class offering, Airsupra is a pressurized metered-dose ...

Asthma inhalers are hand-held devices that allow you to inhale a dose of medication to treat asthma symptoms. There are many ...

AstraZeneca's assault on GlaxoSmithKline’s position as the company selling the most-prescribed combination respiratory drug received a boost yesterday when it presented clinical data claiming ...

AstraZeneca PLCAZN announced positive results from a safety study on Symbicort inhaler in patients suffering from asthma compared to budesonide alone. Symbicort is presently marketed for the ...